for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Markets News

BRIEF-Trillium Therapeutics Reports Qtrly Earnings Per Share Of $0.65

May 11 (Reuters) - Trillium Therapeutics Inc:

* TRILLIUM THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS

* TRILLIUM THERAPEUTICS INC - QTRLY EARNINGS PER SHARE $0.65

* TRILLIUM THERAPEUTICS INC - EXPECT TO ENROLL FIRST PATIENT IN A PHASE 1 CLINICAL TRIAL OF TTI-622 IN Q2 2018

* TRILLIUM - AS OF MARCH 31, 2018, HAD CASH & CASH EQUIVALENTS & MARKETABLE SECURITIES, & WORKING CAPITAL OF $73.9 MILLION AND $61.7 MILLION, RESPECTIVELY Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up